Frank Baylis
Frank Baylis
Main page
392796

Frank Baylis

logo
Community Hub0 subscribers
What are your thoughts?
Be the first to start a discussion here.
Be the first to start a discussion here.
Frank Baylis

Frank Headley Baylis (born November 15, 1962) is a Canadian businessman and politician, who was elected to represent the riding of Pierrefonds-Dollard in the House of Commons of Canada in the 2015 federal election. He did not run for re-election in 2019. In January 2025, he announced his candidacy for leader of the Liberal Party of Canada. Baylis placed fourth in the election, getting 3% of the vote.

Baylis is the Executive Chairman of the Board of Directors of Baylis Medical Technologies, a medical equipment conception, design, development, production and distribution firm.

Frank Baylis' father, Richard Baylis, immigrated to Canada from the United Kingdom in 1956, and his mother, Gloria Baylis (née Clarke), originally from Barbados, immigrated to Canada in 1952. Frank Baylis has three siblings, Dr. Françoise Baylis, Dr. Peter Baylis, and Dr. Penny Baylis. While originally from the Greater Montreal area, Baylis spent part of his youth living in Toronto before attending university. Baylis holds a bachelor's degree in electrical engineering from the University of Waterloo. He graduated in 1986 with honours.

Before being elected to the House of Commons, Frank Baylis was involved in the business of industrial manufacturing and consulting industry. In more recent years, Baylis has also been involved in the entertainment industry.

Frank Baylis' mother, Gloria Baylis, a nurse by profession, founded Baylis Medical Company in the early 1980s, running the business out of the family home. In 1986 Baylis Medical was incorporated as an importer and distributor of medical devices. Frank Baylis joined the company in 1989 to assist with distribution, and served as its president from 1989 to 2015.

From 1990 onwards, the company evolved from a distributor to a developer, manufacturer, and seller of proprietary medical devices with a focus on interventional cardiology and pain management. In 2009, Baylis Medical divested its pain management business to Kimberley-Clark Corporation. At the end of 2015, Baylis Medical divested its OsteoCool™ RF Ablation System and associated intellectual property to Medtronic. After the sale, Baylis Medical partnered with Medtronic to innovate the system further, and manufactured the OsteoCool™ (now under contract to Medtronic) at its Mississauga Ontario plant.

In the spring of 2020 during the COVID-19 pandemic, Ventilators for Canadians (V4C), a consortium of Canadian entrepreneurs, posted plans to develop and manufacture "urgently needed ventilators for hospitals across Canada." FTI Professional Grade Inc. was enlisted as the prime contractor to the federal government, "with Baylis Medical engaged as manufacturing subcontractor and V4C supporting the supply chain and manufacturing process". Scrutiny by the media and opposition parties within the Canadian Federal Government raised questions about conflict of interest in granting the contract to a consortium that subcontracted much of the work involved to a company co-owned by a former member of parliament. On November 27, 2020, the case was discussed by the House of Commons of Canada Standing Committee on Access to Information, Privacy and Ethics, and the Conflict of Interest and Ethics Commissioner found that: "As a former member of Parliament, [Mr. Baylis] is no longer subject to the Conflict of Interest Code for Members of the House of Commons" and that "the contract was not concluded with him." Under Canadian federal law, a "5-year prohibition on lobbying applies to former designated public office holders" [defined in the Lobbying Act, subsection 2(1). On December 4, 2020, Frank Baylis appeared before the same Standing Committee and testified that he had not spoken with the Prime Minister or any cabinet ministers or any members of any political party to "ask them or influence them for a contract".

In October 2021, Baylis Medical agreed to the sale of its cardiovascular medical devices business to Boston Scientific Corporation for US$1.75 billion. The acquisition was completed in February 2022. Concerning the sale, The Globe and Mail reported that "Mr. Baylis, the company's executive chairman, and Kris Shah, its president, co-own the debt-free enterprise, which has never raised outside equity. It's the third time their Montreal-based business has sold a division to a major U.S. company, making them arguably Canada's most successful medical device entrepreneurs."

See all
User Avatar
No comments yet.